Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23

Article  PubMed  PubMed Central  Google Scholar 

Alabousi M, Wadera A, Kashif Al-Ghita M, Kashef Al-Ghetaa R, Salameh JP, Pozdnyakov A et al (2021) Performance of digital breast tomosynthesis, synthetic mammography, and digital mammography in breast cancer screening: a systematic review and meta-analysis. J Natl Cancer Inst 113(6):680–690

Article  PubMed  Google Scholar 

Gao Y, Moy L, Heller SL (2021) Digital breast tomosynthesis: update on technology, evidence, and clinical practice. Radiographics 41(2):321–337

Article  PubMed  Google Scholar 

Ko MJ, Park DA, Kim SH, Ko ES, Shin KH, Lim W, Kwak BS, Chang JM (2021) Accuracy of digital breast tomosynthesis for detecting breast cancer in the diagnostic setting: a systematic review and meta-analysis. Korean J Radiol 22(8):1240–1252

Article  PubMed  PubMed Central  Google Scholar 

Pattacini P, Nitrosi A, Giorgi Rossi P, Duffy SW, Iotti V, Ginocchi V et al (2022) A randomized trial comparing breast cancer incidence and interval cancers after tomosynthesis plus mammography versus mammography alone. Radiology 303(2):256–266

Article  PubMed  Google Scholar 

Gilbert FJ, Tucker L, Young KC (2016) Digital breast tomosynthesis (DBT): a review of the evidence for use as a screening tool. Clin Radiol 71(2):141–150

Article  PubMed  Google Scholar 

ECIBC. European breast cancer guidelines, screening tests: use of tomosynthesis. 2022. European Commission Initiative on Breast Cancer. Last update: 17/06/2022. https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/screening-tests

Moger TA, Swanson JO, Holen ÅS, Hanestad B, Hofvind S (2019) Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in Norway. Eur J Health Econ 20(8):1261–1269

Article  PubMed  PubMed Central  Google Scholar 

Moger TA, Holen Å, Hanestad B, Hofvind S (2022) Costs and effects of implementing digital tomosynthesis in a population-based breast cancer screening program: predictions using results from the To-Be Trial in Norway. Pharmacoecon Open 6(4):495–507

Article  PubMed  PubMed Central  Google Scholar 

Cressman S, Mar C, Sam J, Kan L, Lohrisch C, Spinelli JJ (2021) The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis. CMAJ Open 9(2):E443–E450

Article  PubMed  PubMed Central  Google Scholar 

Slanetz PJ (2020) Digital breast tomosynthesis screening for breast cancer: it is cost-effective! Radiology 297(1):49–50

Article  PubMed  Google Scholar 

Sankatsing VDV, Juraniec K, Grimm SE, Joore MA, Pijnappel RM, de Koning HJ, van Ravesteyn NT (2020) Cost-effectiveness of digital breast tomosynthesis in population-based breast cancer screening: a probabilistic sensitivity analysis. Radiology 297(1):40–48

Article  PubMed  Google Scholar 

Wang J, Phi XA, Greuter MJW, Daszczuk AM, Feenstra TL, Pijnappel RM, Vermeulen KM, Buls N, Houssami N, Lu W, de Bock GH (2020) The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Eur Radiol 30(10):5437–5445

Article  PubMed  PubMed Central  Google Scholar 

Thompson W, Argaez C (2019) Digital breast tomosynthesis for the screening and diagnosis of breast cancer: a review of the diagnostic accuracy, cost-effectiveness and guidelines [internet]. Canadian Agency for Drugs and Technologies in Health, Ottawa

Google Scholar 

Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES et al (2020) Long-term outcomes and cost-effectiveness of breast cancer screening with digital breast tomosynthesis in the United States. J Natl Cancer Inst 112(6):582–589

Article  PubMed  Google Scholar 

Movik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å (2017) Digital breast tomosynthesis with hologic 3D mammography selenia dimensions system for use in breast cancer screening: a single technology assessment [internet]. Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH), Oslo, Norway. Report from the Norwegian Institute of Public Health No. 2017-08

Hunter SA, Morris C, Nelson K, Snyder BJ, Poulton TB (2017) Digital breast tomosynthesis: cost-effectiveness of using private and medicare insurance in community-based health care facilities. AJR Am J Roentgenol 208(5):1171–1175

Article  PubMed  Google Scholar 

Miller JD, Bonafede MM, Herschorn SD, Pohlman SK, Troeger KA, Fajardo LL (2017) Value analysis of digital breast tomosynthesis for breast cancer screening in a US medicaid population. J Am Coll Radiol 14(4):467-474.e5

Article  PubMed  Google Scholar 

Kalra VB, Wu X, Haas BM, Forman HP, Philpotts LE (2016) Cost-effectiveness of tomosynthesis in annual screening mammography. AJR Am J Roentgenol 207(5):1152–1155

Article  PubMed  Google Scholar 

Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD (2015) Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology 274(3):772–780

Article  PubMed  Google Scholar 

Richman IB, Hoag JR, Xu X et al (2019) Adoption of digital breast tomosynthesis in clinical practice. JAMA Intern Med 179(9):1292–1295

Article  PubMed  PubMed Central  Google Scholar 

Battisti F, Mantellini P, Falini P, Ventura L, Giordano L, Saguatti G, Zappa M, Deandrea S, Gorini G (2022) Key performance indicators of breast cancer screening programmes in Italy, 2011–2019. Ann Ist Super Sanita 58(4):244–253

PubMed  Google Scholar 

Bernardi D, Belli P, Benelli E, Brancato B, Bucchi L, Calabrese M, Carbonaro LA, Caumo F, Cavallo-Marincola B, Clauser P, Fedato C, Frigerio A, Galli V, Giordano L, Giorgi Rossi P, Golinelli P, Morrone D, Mariscotti G, Martincich L, Montemezzi S, Naldoni C, Paduos A, Panizza P, Pediconi F, Querci F, Rizzo A, Saguatti G, Tagliafico A, Trimboli RM, Zappa M, Zuiani C, Sardanelli F (2017) Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa). Radiol Med 122(10):723–730

Article  PubMed  PubMed Central  Google Scholar 

Bernardi D, Gentilini MA, De Nisi M, Pellegrini M, Fantò C, Valentini M, Sabatino V, Luparia A, Houssami N (2020) Effect of implementing digital breast tomosynthesis (DBT) instead of mammography on population screening outcomes including interval cancer rates: results of the Trento DBT pilot evaluation. Breast 50:135–140

Article  PubMed  Google Scholar 

The National Guidelines System of the Italian National Institute of Health (2024) Guidelines for the breast cancer screening and diagnosis (ADOLOPMENT of the European guidelines). https://www.iss.it/documents/20126/9314965/LG+507_Screening+e+diagnosi+tumore+mammella_parte+3.pdf/25fa934b-576c-83d4-bc9f-3f5ad5d626ea?t=1712220698175. [Italian] LINEE GUIDA PER LO SCREENING E LA DIAGNOSI DEL TUMORE DELLA MAMMELLA (ADOLOPMENT LINEE GUIDA EUROPEE) Capitolo sull’uso della tomosintesi

Giorgi Rossi P, Mancuso P, Pattacini P, Campari C, Nitrosi A, Iotti V et al (2024) Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium. Eur J Cancer 199:113553.

Article  PubMed  Google Scholar 

Istituto per lo Studio e la Prevenzione Oncologia. Linea guida: “Screening e diagnosi del tumore della mammella (Adolopment LG Europee) - Raccomandazioni fasce di età e intervalli”. Sistema Nazionale Linee Guida dell’Istituto Superiore di Sanità. 2022

Armaroli P, Frigerio A, Correale L, Ponti A, Artuso F, Casella D et al (2022) A randomised controlled trial of digital breast tomosynthesis vs digital mammography as primary screening tests: Screening results over subsequent episodes of the Proteus Donna study. Int J Cancer 151(10):1778–1790

Article  PubMed  Google Scholar 

Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios JM, Shau WY (2014) Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health 17(1):5–14

Article  PubMed  Google Scholar 

Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, Caulley L, Chaiyakunapruk N, Greenberg D, Loder E, Mauskopf J, Mullins CD, Petrou S, Pwu RF, Staniszewska S (2022) Correction to: Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Appl Health Econ Health Policy 20(5):781–782. https://doi.org/10.1007/s40258-022-00743-y. (Erratum for: Appl Health Econ Health Policy. 2022 Ma;20(2):213-221)

Article  PubMed  PubMed Central  Google Scholar 

ONS. I costi dello screening. Libro a cura di Paola Mantellini e Giuseppe Lippi. Osservatorio Nazionale Screening. 2011. Disponibile all’indirizzo: https://www.osservatorionazionalescreening.it/sites/default/files/allegati/Mantellini_PDF_navigabile.pdf. Accessed 2 Nov 2023

Francisci S, Guzzinati S, Capodaglio G, Pierannunzio D, Mallone S, Tavilla A et al (2020) Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data. Eur J Health Econ 21(7):1003–1013

Article  PubMed  Google Scholar 

Khan SA, Hernandez-Villafuerte K, Hernandez D, Schlander M (2023) Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach. Front Public Health 10:946544

Article  PubMed  PubMed Central  Google Scholar 

Giorgi Rossi P, Djuric O, Hélin V, Astley S, Mantellini P, Nitrosi A et al (2021) Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk. Sci Rep 11(1):19884

Article  PubMed  PubMed Central